Literature DB >> 23825194

Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV.

Laura Savolainen1, Anu Kantele, Bettina Sandboge, Marita Sirén, Heikki Valleala, Riitta Tuompo, Liana Pusa, Riitta Erkinjuntti-Pekkanen, Aija Knuuttila, Cheng-Lung Ku, Chih-Yu Chi, Tuula Vasankari, Tamara Tuuminen.   

Abstract

Diagnosis of active tuberculosis by detection of urinary lipoarabinomannan (uLAM) from Mycobacterium tuberculosis is an attractive approach. Concentrating urine 100-fold allowed quantitation of uLAM at levels equal to picograms/ml of nonconcentrated urine. The approach of concentrating urine 100-fold improved the clinical sensitivity of the Clearview TB enzyme-linked immunosorbent assay (ELISA) from 7% to 57% yet impaired its specificity from 97% to 89%. (This study has been registered at University Hospital of Turku under registration no. 47/180/2009, Helsinki University Central Hospital under 149/2010, University Hospital of Kuopio under 105/2010, and China Medical University Hospital, Taichung, under DMR-99-IRB-075-2.).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23825194      PMCID： PMC3889579          DOI： 10.1128/CVI.00375-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  21 in total

Review 1.  Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments.

Authors:  Jonathan Peter; Clare Green; Michael Hoelscher; Peter Mwaba; Alimuddin Zumla; Keertan Dheda
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

2.  Integration of microscopy and serodiagnostic tests to screen for active tuberculosis.

Authors:  G V Kanaujia; P K Lam; S Perry; P N Brusasca; A Catanzaro; M L Gennaro
Journal:  Int J Tuberc Lung Dis       Date:  2005-10       Impact factor: 2.373

3.  Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.

Authors:  Keertan Dheda; Virginia Davids; Laura Lenders; Teri Roberts; Richard Meldau; Daphne Ling; Laurence Brunet; Richard van Zyl Smit; Jonathan Peter; Clare Green; Motasim Badri; Leonardo Sechi; Surendra Sharma; Michael Hoelscher; Rodney Dawson; Andrew Whitelaw; Jonathan Blackburn; Madhukar Pai; Alimuddin Zumla
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

4.  Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.

Authors:  Maunank Shah; Ebrahim Variava; Charles B Holmes; Alison Coppin; Jonathan E Golub; Jeremy McCallum; Michelle Wong; Binu Luke; Desmond J Martin; Richard E Chaisson; Susan E Dorman; Neil A Martinson
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

5.  Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.

Authors:  R Mutetwa; C Boehme; M Dimairo; T Bandason; S S Munyati; D Mangwanya; S Mungofa; A E Butterworth; P R Mason; E L Corbett
Journal:  Int J Tuberc Lung Dis       Date:  2009-10       Impact factor: 2.373

6.  Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study.

Authors:  P Daley; J S Michael; P Hmar; A Latha; P Chordia; D Mathai; K R John; M Pai
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 2.373

7.  Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.

Authors:  Stephen D Lawn; David J Edwards; Katharina Kranzer; Monica Vogt; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

8.  Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis.

Authors:  Celine R Gounder; Tendesayi Kufa; Nikolas I Wada; Victor Mngomezulu; Salome Charalambous; Yasmeen Hanifa; Katherine Fielding; Alison Grant; Susan Dorman; Richard E Chaisson; Gavin J Churchyard
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 9.  Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.

Authors:  Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2012-04-26       Impact factor: 3.090

10.  Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis.

Authors:  Klaus Reither; Elmar Saathoff; Jutta Jung; Lilian T Minja; Inge Kroidl; Eiman Saad; Jim F Huggett; Elias N Ntinginya; Lucas Maganga; Leonard Maboko; Michael Hoelscher
Journal:  BMC Infect Dis       Date:  2009-08-28       Impact factor: 3.090
View more
  11 in total

Review 1.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Authors:  Maunank Shah; Colleen Hanrahan; Zhuo Yu Wang; Nandini Dendukuri; Stephen D Lawn; Claudia M Denkinger; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2016-05-10

Review 2.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.

Authors:  Stephanie Bjerrum; Ian Schiller; Nandini Dendukuri; Mikashmi Kohli; Ruvandhi R Nathavitharana; Alice A Zwerling; Claudia M Denkinger; Karen R Steingart; Maunank Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-10-21

3.  Simple manipulation of enzyme-linked immunosorbent assay (ELISA) using an automated microfluidic interface.

Authors:  Yosita Panraksa; Ilhoon Jang; Cody S Carrell; Anita G Amin; Orawon Chailapakul; Delphi Chatterjee; Charles S Henry
Journal:  Anal Methods       Date:  2022-05-13       Impact factor: 3.532

4.  The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis.

Authors:  Conrad E Chan; Sebastian Götze; Geok T Seah; Peter H Seeberger; Nestan Tukvadze; Markus R Wenk; Brendon J Hanson; Paul A MacAry
Journal:  Sci Rep       Date:  2015-05-15       Impact factor: 4.379

Review 5.  Pathogen-derived biomarkers for active tuberculosis diagnosis.

Authors:  Paula Tucci; Gualberto González-Sapienza; Monica Marin
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

6.  Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.

Authors:  Phindile Gina; Philippa J Randall; Tapuwa E Muchinga; Anil Pooran; Richard Meldau; Jonny G Peter; Keertan Dheda
Journal:  BMC Infect Dis       Date:  2017-05-12       Impact factor: 3.090

Review 7.  Mycobacteria-derived biomarkers for tuberculosis diagnosis.

Authors:  Magdalena Druszczynska; Sebastian Wawrocki; Rafal Szewczyk; Wieslawa Rudnicka
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

8.  The Diagnostic Laboratory Hub: A New Health Care System Reveals the Incidence and Mortality of Tuberculosis, Histoplasmosis, and Cryptococcosis of PWH in Guatemala.

Authors:  B Samayoa; L Aguirre; O Bonilla; N Medina; D Lau-Bonilla; D Mercado; A Moller; J C Perez; A Alastruey-Izquierdo; E Arathoon; D W Denning; J L Rodríguez-Tudela
Journal:  Open Forum Infect Dis       Date:  2019-12-15       Impact factor: 3.835

9.  A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.

Authors:  George B Sigal; Abraham Pinter; Todd L Lowary; Masanori Kawasaki; Andra Li; Anu Mathew; Michael Tsionsky; Ruixiang Blake Zheng; Tatiana Plisova; Ke Shen; Kiyonori Katsuragi; Alok Choudhary; William J Honnen; Payam Nahid; Claudia M Denkinger; Tobias Broger
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

Review 10.  Future perspectives of wastewater-based epidemiology: Monitoring infectious disease spread and resistance to the community level.

Authors:  Natalie Sims; Barbara Kasprzyk-Hordern
Journal:  Environ Int       Date:  2020-04-04       Impact factor: 9.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.